833-489-4968

Nonalcoholic Fatty Liver Disease

  • Home
  • Atherosclerotic Cardiovascular Disease (ASCVD)

What is Nonalcoholic Fatty Liver Disease? Understanding Liver Health Beyond Alcohol Use

Nonalcoholic Fatty Liver Disease (NAFLD) is a condition in which excess fat builds up in the liver of individuals who consume little to no alcohol. NAFLD has become one of the most common liver disorders worldwide, affecting an estimated 25% of adults globally. It often occurs in people who are overweight, diabetic, or have metabolic syndrome — though it can also affect individuals with no prior liver history.

NAFLD ranges in severity from simple steatosis (fat accumulation) to nonalcoholic steatohepatitis (NASH), a more serious form involving inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or liver cancer.

Symptoms of NAFLD

Many people with NAFLD experience no noticeable symptoms in the early stages, making it difficult to detect without a medical exam. However, as the disease progresses, symptoms may include:

  • Fatigue or Weakness: General low energy or tiredness

  • Upper Right Abdominal Discomfort: Mild or persistent pain near the liver

  • Unexplained Weight Loss: Particularly in later stages of NASH

  • Enlarged Liver: Often detected during routine exams

  • Signs of Liver Dysfunction: In severe cases, jaundice, swelling, or confusion

Due to its silent nature, NAFLD is frequently discovered through blood tests, imaging, or during evaluations for other conditions.

Diagnosing Nonalcoholic Fatty Liver Disease

Early detection is key to preventing NAFLD from progressing to life-threatening liver conditions. Common diagnostic methods include:

  • Blood Tests: Checking for elevated liver enzymes or signs of insulin resistance

  • Imaging Studies: Ultrasound, CT scan, or MRI to visualize fat buildup

  • FibroScan or Elastography: Measures liver stiffness, indicating fibrosis

  • Liver Biopsy: In some cases, a biopsy is performed to assess inflammation and scarring

Clinical research centers may also use non-invasive diagnostic tools and biomarkers to assess disease progression and response to treatment.

Current Treatments for NAFLD

There is currently no FDA-approved medication specifically for NAFLD or NASH. Management typically focuses on lifestyle changes and treating associated metabolic conditions:

  • Weight Loss: A 7–10% reduction in body weight can significantly improve liver health

  • Healthy Diet: Emphasis on whole grains, lean proteins, fruits, and vegetables while reducing sugar and saturated fats

  • Exercise: Regular physical activity improves liver function and reduces fat accumulation

  • Diabetes and Cholesterol Control: Medications may be prescribed to manage related conditions

  • Avoiding Alcohol and Unnecessary Medications: Reducing liver stress

In advanced cases, liver transplant may be required, underscoring the need for early intervention and ongoing research.

The Role of Clinical Research in NAFLD Treatment

As NAFLD rates increase, so does the urgency for effective treatment options. Clinical trials are exploring new therapies aimed at reducing liver fat, inflammation, and scarring — offering hope for slowing or reversing disease progression.

Benefits of Participating in Clinical Research:

  • Access to Investigational Therapies: Try new medications that may not be publicly available yet

  • Enhanced Monitoring and Care: Frequent health evaluations, lab testing, and imaging

Contribution to Medical Advancement: Help researchers develop effective treatments for future patients living with NAFLD

How BioResearch Partner Supports NAFLD Research

BioResearch Partner collaborates with hepatologists, endocrinologists, and research sponsors to drive high-quality NAFLD studies in the Miami area. Our team ensures that patients are supported from initial screening through study completion.

Why Choose BioResearch Partner?

  • Specialized Research Teams: Trained in liver disease protocols and patient care

  • Advanced Study Designs: Prioritizing safety, comfort, and outcome accuracy

  • Diverse Patient Engagement: Ensuring inclusive trials that reflect real-world populations

Our infrastructure helps move liver disease research forward — efficiently and ethically.

Participate in a Clinical Trial and Help Shape the Future of Liver Care

If you or a loved one has been diagnosed with NAFLD or is at risk, participating in a clinical trial may offer access to cutting-edge treatments and comprehensive medical oversight. At BioResearch Partner, we are actively enrolling for NAFLD and NASH studies that may improve outcomes for individuals just like you.

📞 Call: 833-489-4978
 🌐 Visit: www.bioresearchpartner.com
 📩 Email: info@bioresearchpartner.com

Become a BioResearch Partner

Our associates eagerly anticipate your communication. Please feel free to contact us at your earliest convenience to arrange a meeting and obtain further information. Alternatively, you may complete our form, and we will promptly reach out to provide the requested information.

Call Us Now